USA Passive

iShares U.S. Pharmaceuticals ETF

The iShares U.S. Pharmaceuticals ETF (the “Fund”) seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.

$64.92

Compare similar ETFs

Fund Size
Dividend
Fees
Current
U.S. Pharmaceuticals ETF IHE
Fund Size
$626 Million
Dividend
1.8%
Fees
0.39%
Core S&P 500 ETF IVV
Fund Size
$590 Billion
Dividend
1.5%
Fees
0.03%
Core U.S. Aggregate Bond ETF AGG
Fund Size
$126 Billion
Dividend
4.1%
Fees
0.03%
S&P 500 Equal Weight ETF RSP
Fund Size
$77.7 Billion
Dividend
1.7%
Fees
-
Schwab U.S. Dividend Equity ETF SCHD
Fund Size
$68 Billion
Dividend
4.1%
Fees
0.06%
View 398 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $314 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.84 %
Beta Indicates the relationship between the price performance of a share and the market. 0.5746
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 37.47
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -67.12
Profitable Companies 79
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 104.02
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 9.52
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 21.67
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT 24.65
Enterprise Value to Revenue Enterprise value divided by revenue 23.11
Total Debt to Enterprise Value Total debt divided by enterprise value 0.12
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.8702
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -209.29%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. 14.00%
Return on Assets Indicates a company's profitability in relation to its total assets. 0.02%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 5.21%

Industries

Healthcare 73.3%
Other 2.2%
N/A 24.4%

Market cap

Micro Cap 3%
Small Cap 8%
Mid Cap 12%
Large Cap 19%
Mega Cap 57%

45 Investments

P/E-Ratio
Total Investment
Weight
JOHNSON & JOHNSON logo

JNJ - Manufacturing

JOHNSON & JOHNSON

P/E-Ratio
26.9
Total Investment
$145 Million
Weight
23.7%
ELI LILLY AND COMPANY logo

LLY - Manufacturing

ELI LILLY AND COMPANY

P/E-Ratio
71.7
Total Investment
$143 Million
Weight
23.3%
PFIZER INC. logo

PFIZER INC.

P/E-Ratio
n/a
Total Investment
$30.9 Million
Weight
5.1%
BRISTOL-MYERS SQUIBB CO logo

BMY - Manufacturing

BRISTOL-MYERS SQUIBB CO

P/E-Ratio
-16.7
Total Investment
$29.4 Million
Weight
4.8%
MERCK & CO., INC. logo

MERCK & CO., INC.

P/E-Ratio
n/a
Total Investment
$29.3 Million
Weight
4.8%
VIATRIS INC. logo

VIATRIS INC.

P/E-Ratio
n/a
Total Investment
$28.7 Million
Weight
4.7%
ZOETIS INC. logo

ZTS - Manufacturing

ZOETIS INC.

P/E-Ratio
27.2
Total Investment
$27 Million
Weight
4.4%
ROYALTY PHARMA PLC logo

RPRX - Manufacturing

ROYALTY PHARMA PLC

P/E-Ratio
17.0
Total Investment
$22.5 Million
Weight
3.7%
Intra-Cellular Therapies Inc logo

ITCI - Manufacturing

Intra-Cellular Therapies Inc

P/E-Ratio
-182.1
Total Investment
$19 Million
Weight
3.1%
JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY logo

JAZZ - Manufacturing

JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY

P/E-Ratio
11.1
Total Investment
$17.2 Million
Weight
2.8%
BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares logo

BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares

P/E-Ratio
n/a
Total Investment
$15.5 Million
Weight
2.5%
ELANCO ANIMAL HEALTH INCORPORATED logo

ELAN - Manufacturing

ELANCO ANIMAL HEALTH INCORPORATED

P/E-Ratio
12.3
Total Investment
$13.8 Million
Weight
2.3%
CORCEPT THERAPEUTICS INCORPORATED logo

CORT - Manufacturing

CORCEPT THERAPEUTICS INCORPORATED

P/E-Ratio
45.7
Total Investment
$10.8 Million
Weight
1.8%
PRESTIGE CONSUMER HEALTHCARE INC. logo

PRESTIGE CONSUMER HEALTHCARE INC.

P/E-Ratio
n/a
Total Investment
$8.9 Million
Weight
1.5%
ORGANON & CO. logo

OGN - Manufacturing

ORGANON & CO.

P/E-Ratio
3.3
Total Investment
$8.87 Million
Weight
1.5%
PERRIGO COMPANY PUBLIC LIMITED COMPANY logo

PRGO - Manufacturing

PERRIGO COMPANY PUBLIC LIMITED COMPANY

P/E-Ratio
-20.8
Total Investment
$8.09 Million
Weight
1.3%
AXSOME THERAPEUTICS, INC. logo

AXSM - Manufacturing

AXSOME THERAPEUTICS, INC.

P/E-Ratio
-17.4
Total Investment
$7.95 Million
Weight
1.3%
LIGAND PHARMACEUTICALS INCORPORATED logo

LGND - Manufacturing

LIGAND PHARMACEUTICALS INCORPORATED

P/E-Ratio
-494.0
Total Investment
$4.67 Million
Weight
0.8%
SUPERNUS PHARMACEUTICALS, INC. logo

SUPN - Manufacturing

SUPERNUS PHARMACEUTICALS, INC.

P/E-Ratio
22.9
Total Investment
$4.61 Million
Weight
0.8%
Tarsus Pharmaceuticals Inc logo

TARS - Manufacturing

Tarsus Pharmaceuticals Inc

P/E-Ratio
-8.5
Total Investment
$4.45 Million
Weight
0.7%
Edgewise Therapeutics Inc logo

EWTX - Manufacturing

Edgewise Therapeutics Inc

P/E-Ratio
-9.3
Total Investment
$3.62 Million
Weight
0.6%
WAVE Life Sciences Ltd logo

WVE - Manufacturing

WAVE Life Sciences Ltd

P/E-Ratio
-9.9
Total Investment
$3.35 Million
Weight
0.5%
AMPHASTAR PHARMACEUTICALS INC logo

AMPH - Manufacturing

AMPHASTAR PHARMACEUTICALS INC

P/E-Ratio
7.0
Total Investment
$3.21 Million
Weight
0.5%
HARMONY BIOSCIENCES HOLDINGS, INC. logo

HARMONY BIOSCIENCES HOLDINGS, INC.

P/E-Ratio
n/a
Total Investment
$3.03 Million
Weight
0.5%
Arvinas Inc logo

ARVN - Manufacturing

Arvinas Inc

P/E-Ratio
-3.1
Total Investment
$2.83 Million
Weight
0.5%